<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00930618</url>
  </required_header>
  <id_info>
    <org_study_id>P071212</org_study_id>
    <nct_id>NCT00930618</nct_id>
  </id_info>
  <brief_title>Reduction of Cesareans by Nitric Oxide (NO) Donors in Post Term Pregnancies</brief_title>
  <acronym>NOCETER</acronym>
  <official_title>NOCETER, a Multicenter Double Blind Placebo-controlled Randomized Trial: Reduction of CEsareans in Post TERm Pregnancies: Impact of Outpatient Cervical Ripening With NO Donors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to determine whether cervical ripening with isosorbide
      mononitrate reduce caesarean section in women with post term pregnancies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this trial is to determine whether cervical ripening with 40 mg of isosorbide
      mononitrate given intravaginally at 41+0, 41+2 and 41+4 weeks reduce cesarean section in
      nullipara with post term pregnancies. Treatments will be administered by midwifes in the
      maternity wards, women will be allowed to go back home in case of Bishop score&lt;6. Otherwise
      labor will be induced with oxytocin. If undelivered at 41+5, women with Bishop score&lt;6 will
      be induced with prostaglandins according to local protocols.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of cesarean sections</measure>
    <time_frame>10 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of labor inductions</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of spontaneous labors</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cesarean for failed labor induction</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cesarean for FHR abnormalities</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cesarean for arrested labor</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean time between randomisation and spontaneous labor</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Isosorbide mononitrate adverse effects</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal satisfaction</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal morbidity</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean time between randomisation and delivery</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean duration of labor</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1409</enrollment>
  <condition>Prolonged Pregnancy</condition>
  <condition>Nulliparity</condition>
  <arm_group>
    <arm_group_label>IMN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Isosorbide mononitrate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Administration of placebo of IMN</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IMN</intervention_name>
    <description>Administration of 2 x 20 mg of isosorbide mononitrate at each administration with a maximum of three administrations</description>
    <arm_group_label>IMN</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Administration of 2 X 20 mg of placebo of IMN at each administration with a maximum of three administration</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria :

          -  Age &gt; or = 18 years old

          -  TAS &gt; or = 95 mmHg

          -  Singleton

          -  Nulliparity

          -  Term &gt; or = 41 weeks + 0 day

          -  Bishop score &lt; or = 5

          -  Vertex presentation

          -  Intact membranes

          -  No contra-indications of the study treatment

          -  No maternal or fetal diseases which could indicate immediate labor induction

          -  Written informed consent

        Exclusion criteria :

          -  Multiple pregnancy

          -  Multiparity

          -  Term &lt; 41 weeks

          -  Bishop score &gt; 5

          -  Breech presentation

          -  Rupture of the membranes

          -  Previous cesarean

          -  Indication to immediate labor induction

          -  Contraindications to isosorbide mononitrate

          -  No co-administration of antihypertensive drugs

          -  No social security
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François Goffinet, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Scientific Responsible</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Robert Debré Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2009</study_first_submitted>
  <study_first_submitted_qc>June 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2009</study_first_posted>
  <last_update_submitted>December 20, 2016</last_update_submitted>
  <last_update_submitted_qc>December 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prolonged pregnancy</keyword>
  <keyword>Nulliparity</keyword>
  <keyword>Cervical ripening</keyword>
  <keyword>Induced labor</keyword>
  <keyword>Cesarean section</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregnancy, Prolonged</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Isosorbide-5-mononitrate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

